Novartis | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 10.92B 553M 2024-12
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Bausch Health Companies USD 2.09B 8M 2024-09
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 271M 10M 2024-09
J&J USD 14.84B 1.33B 2024-12
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prestige Brands USD 167.27M 3.73M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.8B 2.24B 2024-06
Sanofi 8.8B 2.24B 2024-06
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
Zoetis USD 1.32B 95M 2024-12



Novartis Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.